New Versant Ventures startup goes ‘gutless’ for next-generation gene delivery

New Versant Ventures startup goes ‘gutless’ for next-generation gene delivery

Source: 
MedCity News
snippet: 

Vector BioPharma has launched from the biotech startup incubator of Versant Ventures, which is backing the company with a $30 million Series A financing. Vector is developing virus-like particles with the capability to deliver large payloads of genetic medicines to a wide range of tissues.